VHT logo

Vanguard Health Care ETF (VHT)

$292.72

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on VHT

AUM

$17.45B

P/E ratio

24.2

Dividend yield

1.6366%

Expense ratio

0.09%

Beta

0.650558

Price on VHT

Previous close

$289.90

Today's open

$290.60

Day's range

$290.30 - $293.19

52 week range

$234.11 - $298.61

Profile about VHT

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

VHT industries and sectors

Industries

Health

Top holdings in VHT

4.94%

News on VHT

Should You Invest in the Vanguard Health Care ETF (VHT)?

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Vanguard Health Care ETF (VHT) is a passively managed exchange traded fund launched on January 26, 2004.

news source

Zacks Investment Research • Feb 10, 2026

news preview

3 Must-Buy ETFs if You Want to De-Risk Your Portfolio Ahead of a Recession

The broader market is sending a clear signal as speculative assets like cryptocurrencies have taken a dive.

news source

24/7 Wall Street • Feb 9, 2026

news preview

ETFs to Play as Investors Chase Diversification Amid Tech Rout

From "software-mageddon" to rising AI capex pressuring Big Tech, diversification via defensive and global ETFs gains focus.

news source

Zacks Investment Research • Feb 6, 2026

news preview

3 Healthcare ETFs to Buy as Flat Medicare Rate Proposal Hits Insurers

Flat Medicare Advantage rate hikes hit insurers hard, but diversified healthcare ETFs may help investors weather the policy shock.

news source

Zacks Investment Research • Jan 27, 2026

news preview

This Is My No. 1 Recommended Vanguard ETF to Buy in 2026

Vanguard's low-fee mutual funds and ETFs make it easy for individual investors to build diversified portfolios. The Vanguard Health Care ETF has outperformed the S&P 500 over the past six months.

news source

The Motley Fool • Jan 18, 2026

news preview

This ETF Is Proof That the Healthcare Rebound Is Real

With well-publicized losses for companies including UnitedHealth Group NYSE: UNH, Elevance Health NYSE: ELV, and Wegovy and Ozempic maker Novo Nordisk NYSE: NVO, the healthcare sector failed to outperform the broad market last year.

news source

MarketBeat • Jan 11, 2026

news preview

There Is a Quiet But Massive Migration Away From Tech Stocks in 2026

In the last three months of 2025, the tech sector experienced what some called a “correction”.

news source

24/7 Wall Street • Jan 9, 2026

news preview

Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond

After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.

news source

Zacks Investment Research • Jan 9, 2026

news preview

As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight

Health care ETFs could emerge as one of the stronger performers in 2026 as investors grow cautious about pricey AI stocks.

news source

Benzinga • Jan 6, 2026

news preview

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus

The approval of Novo Nordisk's (NYSE: NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to choose one specific company.

news source

Benzinga • Dec 23, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Vanguard Health Care ETF

Open an M1 investment account to buy and sell Vanguard Health Care ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in VHT on M1